Toll-Like Receptor Agonists

DBCAT005893Pharmacologic class

Agents that stimulate TOLL-LIKE RECEPTOR signaling, and the activity of both the INNATE IMMUNE RESPONSE and ADAPTIVE IMMUNITY. A DrugBank category of 2 drugs. 1 of them is approved.

Drugs: Imiquimod
Resiquimod

What you can answer from here — as of December 03, 2023

2DrugsEach linked to its full drug card

Listed above

2Drug targetsEvery drug–target pair in the class, with bond type

81Marketed productsAcross the regions we cover, with dosage forms and routes

2Routes of administrationHow the drugs in this class are given

Which targets do Toll-Like Receptor Agonists share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account